AUTOIMMUNE RETINOPATHY AND ANTIRETINAL ANTIBODIES: A REVIEW
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
In Brief Purpose: To review the current state for diagnosis and management of autoimmune retinopathy. Methods: A review of the literature was performed, encompassing autoimmune retinopathy including paraneoplastic retinopathy (cancer-associated retinopathy, melanoma-associated retinopathy, and bilateral diffuse uveal melanocytic proliferation) and non-paraneoplastic autoimmune retinopathy. Based on this review, current principles and techniques for diagnosis and the treatments reported for autoimmune retinopathy are discussed with the aim to clarify some of the confusion that exists regarding this complex entity. Results: Autoimmune retinopathy encompasses a spectrum of retinal degeneration phenotypes. The clinical features, fundus characteristics, and electroretinogram findings for paraneoplastic and non-paraneoplastic retinopathy are reviewed. The different antiretinal antibodies reported in these entities are described. The diagnostic approaches for detecting these antiretinal antibodies and their limitations are covered. The treatments reported for autoimmune retinopathy and their outcomes are reviewed. Conclusion: Among the myriad of antiretinal antibodies reported, challenges persist in determining which antibodies are pathogenic and which are benign and what factors cause antiretinal antibodies to become pathologic. There also remain difficulties in the detection and accurate measurement of antiretinal antibodies, and the response to therapeutic intervention in autoimmune retinopathy is variable. This review covers autoimmune retinopathy describing paraneoplastic retinopathy (cancer-associated retinopathy, melanoma-associated retinopathy, and bilateral diffuse uveal melanocytic proliferation) and non-paraneoplastic autoimmune retinopathy. The diagnostic utility and methods for detecting antiretinal antibodies associated with autoimmune retinopathy are discussed. The various treatments published for autoimmune retinopathy and their reported outcomes are reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunological and Aetiological Aspects of Macular Degeneration
Penfold, P. L., Madigan, M. C., Gillies, M. C., & Provis, J. M. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(00)00025-2 · Cited by 460
Circulating anti-retinal antibodies as immune markers in age-related macular degeneration
Patel, N., Ohbayashi, M., Nugent, A. K., Ramchand, K., Toda, M., Chau, K., Bunce, C., Webster, A., Bird, A. C., Ono, S. J., et al. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02173.x · Cited by 125
den Hollander, A. I., McGee, T. L., Ziviello, C., Banfi, S., Dryja, T. P., Gonzalez-Fernandez, F., Ghosh, D., & Berson, E. L. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2497 · Cited by 109 · cited 4×
“At present, there is no definite evidence of tumor activity in npAIR, though it has been suggested to be theoretically possible.93 Thinning of the outer nuclear layer and an irregular ellipsoid layer have been demonstrated on spectral domain optical coherence tomography along with a reduction in full-field ERG.94 Some…”
BackgroundInfluentialThe Role of Anti-α-Enolase Autoantibodies in Pathogenicity of Autoimmune-Mediated Retinopathy
MAGRYS, A., ANEKONDA, T., REN, G., & ADAMUS, G. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-006-9065-8 · Cited by 95
Research works printed but not linked: 111
- Weleber, 2005, . Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies., Am J Ophthalmol, 139, 780, 10.1016/j.ajo.2004.12.104 · DOI · Paper page
- Jampol, 2004, . Multiple serous retinal detachments and subretinal deposits as the presenting signs of metastatic melanoma., Retina, 24, 320, 10.1097/00006982-200404000-00028 · DOI
- Pelosof, 2010, Paraneoplastic syndromes: an approach to diagnosis and treatment., Mayo Clin Proc, 85, 838, 10.4065/mcp.2010.0099 · DOI · Paper page
- Forooghian, 2008, . The need for standardization of antiretinal antibody detection and measurement., Am J Ophthalmol, 146, 489, 10.1016/j.ajo.2008.05.046 · DOI
- Whitcup, 1998, . Recoverin-associated retinopathy: a clinically and immunologically distinctive disease., Am J Ophthalmol, 126, 230, 10.1016/S0002-9394(98)00149-4 · DOI
- Adamus, 2004, Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy., BMC Ophthalmol, 4, 1, 10.1186/1471-2415-4-5 · DOI · Paper page
- Keltner, 1992, . Management and monitoring of cancer-associated retinopathy., Arch Ophthalmol, 110, 48, 10.1001/archopht.1992.01080130050025 · doi:10.1001/archopht.1992.01080130050025
- Sawyer, 1976, . Blindness caused by photoreceptor degeneration as a remote effect of cancer., Am J Ophthalmol, 81, 606, 10.1016/0002-9394(76)90125-2 · doi:10.1016/0002-9394(76)90125-2
- Polans, 1993, . Recoverin, but not visinin, is an autoantigen in the human retina identified with a cancer-associated retinopathy., Invest Ophthalmol Vis Sci, 34, 81
- Polans, 1995, . Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy., Proc Natl Acad Sci U S A, 92, 9176, 10.1073/pnas.92.20.9176 · DOI · Paper page
- Guy, 1999, Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases., Arch Ophthalmol, 117, 471, 10.1001/archopht.117.4.471 · doi:10.1001/archopht.117.4.471
- Goldstein, 1999, . Cancer-associated retinopathy., Arch Ophthalmol, 117, 1641, 10.1001/archopht.117.12.1641 · doi:10.1001/archopht.117.12.1641
- Adamus, 1998, . Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy., Arch Ophthalmol, 116, 251
- Eltabbakh, 1995, Paraneoplastic retinopathy associated with uterine sarcoma., Gynecol Oncol, 58, 120, 10.1006/gyno.1995.1194 · doi:10.1006/gyno.1995.1194
- Heckenlively, 2000, . Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration., Arch Ophthalmol, 118, 1525, 10.1001/archopht.118.11.1525 · DOI · Paper page
- Heckenlively, 2008, Autoimmune retinopathy: a review and summary., Semin Immunopathol, 30, 127, 10.1007/s00281-008-0114-7 · DOI · Paper page
- Adamus, 2009, Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy., Autoimmun Rev, 8, 410, 10.1016/j.autrev.2009.01.002 · DOI · Paper page
- Khan, 2006, Cancer associated retinopathy (CAR): an autoimmune-mediated paraneoplastic syndrome., Semin Ophthalmol, 21, 135, 10.1080/08820530500350662 · DOI
- Scholl, 2000, Electrophysiology in the investigation of acquired retinal disorders., Surv Ophthalmol, 45, 29, 10.1016/S0039-6257(00)00125-9 · DOI
- Spaide, 2011, Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model., Retina, 31, 1609, 10.1097/IAE.0b013e3182247535 · DOI · Paper page
- Pepple, 2013, . SD-OCT and autofluorescence characteristics of autoimmune retinopathy., Br J Ophthalmol, 97, 139, 10.1136/bjophthalmol-2012-302524 · doi:10.1136/bjophthalmol-2012-302524
- Lima, 2012, . Hyperautofluorescent ring in autoimmune retinopathy., Retina, 32, 1385, 10.1097/IAE.0b013e3182398107 · DOI
- Thirkill, 1992, . The cancer-associated retinopathy antigen is a recoverin-like protein., Invest Ophthalmol Vis Sci, 33, 2768
- Bazhin, 2007, . Recoverin as a cancer-retina antigen., Cancer Immunol Immunother, 56, 110, 10.1007/s00262-006-0132-z · DOI
- Adamus, 2006, . Anti-recoverin antibodies induce an increase in intracellular calcium, leading to apoptosis in retinal cells., J Autoimmun, 26, 146, 10.1016/j.jaut.2005.11.007 · DOI
- Thirkill, 1997, Experimental, cancer-induced retinopathy., Ocul Immunol Inflamm, 5, 55, 10.3109/09273949709085051 · DOI
- Shiraga, 2002, Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway., J Neuroimmunol, 132, 72, 10.1016/S0165-5728(02)00314-4 · DOI
- Mizener, 1997, . Autoimmune retinopathy in the absence of cancer., Am J Ophthalmol, 123, 607, 10.1016/S0002-9394(14)71073-6 · DOI
- Adamus, 1996, . The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy., Clin Immunol Immunopathol, 78, 120, 10.1006/clin.1996.0021 · DOI · Paper page
- Mosca, 2006, . Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus., J Rheumatol, 33, 695
- Heckenlively, 1999, Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa., Am J Ophthalmol, 127, 565, 10.1016/S0002-9394(98)00446-2 · DOI
- Grossman, 2011, . Immunocytochemical evidence of Tulp1-dependent outer segment protein transport pathways in photoreceptor cells., Exp Eye Res, 93, 658, 10.1016/j.exer.2011.08.005 · DOI
- Kikuchi, 2000, . Tubby-like protein 1 as an autoantigen in cancer-associated retinopathy., J Neuroimmunol, 103, 26, 10.1016/S0165-5728(99)00163-0 · DOI
- Ohguro, 1999, Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy., Invest Ophthalmol Vis Sci, 40, 82
- Hsu, 1990, Glyceraldehyde-3-phosphate dehydrogenase is a major protein associated with the plasma membrane of retinal photoreceptor outer segments., J Biol Chem, 265, 13308, 10.1016/S0021-9258(19)38299-7 · DOI · Paper page
- Adamus, 2011, . Diversity in autoimmunity against retinal, neuronal, and axonal antigens in acquired neuro-retinopathy., J Ophthalmic Inflamm Infect, 1, 111, 10.1007/s12348-011-0028-8 · DOI
- Ferreyra, 2009, . Management of autoimmune retinopathies with immunosuppression., Arch Ophthalmol, 127, 390, 10.1001/archophthalmol.2009.24 · DOI · Paper page
- Murphy, 1997, Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma., J Neuroophthalmol, 17, 77, 10.1097/00041327-199706000-00001 · DOI
- Huynh, 2012, . Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy., J Ophthalmic Inflamm Infect, 2, 169, 10.1007/s12348-012-0067-9 · doi:10.1007/s12348-012-0067-9
- Or, 2013, . Intravenous rituximab for the treatment of cancer-associated retinopathy., Can J Ophthalmol, 48, e35, 10.1016/j.jcjo.2012.11.010 · DOI
- Mahdi, 2010, . A case of autoimmune retinopathy associated with thyroid carcinoma., Ocul Immunol Inflamm, 18, 322, 10.3109/09273941003802379 · DOI
- Espandar, 2007, . Successful treatment of cancer-associated retinopathy with alemtuzumab., J Neurooncol, 83, 295, 10.1007/s11060-006-9326-7 · doi:10.1007/s11060-006-9326-7
- Prins, 2007, Intravenous immunoglobulin: properties, mode of action and practical use in dermatology., Acta Derm Venereol, 87, 206, 10.2340/00015555-0249 · DOI
- Kiratli, 1997, . Paraneoplastic retinopathy associated with metastatic cutaneous melanoma of unknown primary site., Eye (Lond), 11, 889, 10.1038/eye.1997.227 · doi:10.1038/eye.1997.227
- Keltner, 2001, Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases., J Neuroophthalmol, 21, 173, 10.1097/00041327-200109000-00004 · DOI · Paper page
- Okel, 1995, An unusual case of melanoma-associated retinopathy., Ocul Immunol Inflamm, 3, 121, 10.3109/09273949509085040 · doi:10.3109/09273949509085040
- Nieuwendijk, 2007, Paraneoplastic vitelliform retinopathy associated with metastatic choroidal melanoma., Eye (Lond), 21, 1436, 10.1038/sj.eye.6702949 · DOI
- Grunwald, 2011, Acute exudative polymorphous paraneoplastic vitelliform maculopathy in a patient with carcinoma, not melanoma., Arch Ophthalmol, 129, 1104, 10.1001/archophthalmol.2011.215 · doi:10.1001/archophthalmol.2011.215
- Koreen, 2011, . Anti-retinal pigment epithelium antibodies in acute exudative polymorphous vitelliform maculopathy: a new hypothesis about disease pathogenesis., Arch Ophthalmol, 129, 23, 10.1001/archophthalmol.2010.316 · DOI
- Borkowski, 2001, . Retinal findings in melanoma-associated retinopathy., Am J Ophthalmol, 132, 273, 10.1016/S0002-9394(01)00915-1 · doi:10.1016/s0002-9394(01)00915-1
- Zacks, 2001, . Melanoma-associated retinopathy and recurrent exudative retinal detachments in a patient with choroidal melanoma., Am J Ophthalmol, 132, 578, 10.1016/S0002-9394(01)01086-8 · DOI
- Milam, 1993, . Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy., Invest Ophthalmol Vis Sci, 34, 91
- Potter, 2002, . Autoantibodies to transducin in a patient with melanoma-associated retinopathy., Am J Ophthalmol, 134, 128, 10.1016/S0002-9394(02)01431-9 · DOI
- Hartmann, 2005, . SEREX identification of new tumor antigens linked to melanoma-associated retinopathy., Int J Cancer, 114, 88, 10.1002/ijc.20762 · DOI
- Bazhin, 2009, The need for standardization of antiretinal antibody detection and measurement., Am J Ophthalmol, 147, 374, 10.1016/j.ajo.2008.10.014 · doi:10.1016/j.ajo.2008.10.014
- Eksandh, 2008, . Autoantibodies against bestrophin in a patient with vitelliform paraneoplastic retinopathy and a metastatic choroidal malignant melanoma., Arch Ophthalmol, 126, 432, 10.1001/archopht.126.3.432 · DOI
- Marmorstein, 2000, . Bestrophin, the product of the best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium., Proc Natl Acad Sci U S A, 97, 12758, 10.1073/pnas.220402097 · DOI · Paper page
- Morgans, 2009, . TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells., Proc Natl Acad Sci U S A, 106, 19174, 10.1073/pnas.0908711106 · DOI · Paper page
- Kondo, 2011, . Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction., PLoS One, 6, e19911, 10.1371/journal.pone.0019911 · DOI
- Dhingra, 2011, . Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells., J Neurosci, 31, 3962, 10.1523/JNEUROSCI.6007-10.2011 · doi:10.1523/jneurosci.6007-10.2011
- Nakamura, 2010, . TRPM1 mutations are associated with the complete form of congenital stationary night blindness., Mol Vis, 16, 425
- Wang, 2012, . Autoantibody against transient receptor potential M1 cation channels of retinal ON bipolar cells in paraneoplastic vitelliform retinopathy., BMC Ophthalmol, 12, 56, 10.1186/1471-2415-12-56 · DOI
- Arai, 1994, . Position-independent, high-level, and correct regional expression of the rat aldolase C gene in the central nervous system of transgenic mice., Eur J Biochem, 221, 253, 10.1111/j.1432-1033.1994.tb18736.x · DOI
- Caffe, 1994, . Distribution of Purkinje cell-specific Zebrin-IIaldolase C immunoreactivity in the mouse, rat, rabbit, and human retina., J Comp Neurol, 348, 291, 10.1002/cne.903480210 · doi:10.1002/cne.903480210
- Tanito, 2006, . Identification of 4-hydroxynonenal-modified retinal proteins induced by photooxidative stress prior to retinal degeneration., Free Radic Biol Med, 41, 1847, 10.1016/j.freeradbiomed.2006.09.012 · DOI
- Lu, 2009, . Melanoma-associated retinopathy: a paraneoplastic autoimmune complication., Arch Ophthalmol, 127, 1572, 10.1001/archophthalmol.2009.311 · DOI
- Ahn, 2006, . Identification of an anti-aldolase autoantibody as a diagnostic marker for diabetic retinopathy by immunoproteomic analysis., Proteomics, 6, 1200, 10.1002/pmic.200500457 · DOI
- Morohoshi, 2009, . Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration., J Autoimmun, 33, 247, 10.1016/j.jaut.2009.09.003 · DOI
- Ukaji, 1999, . Serum samples of patients with rheumatoid arthritis contain a specific autoantibody to denatured aldolase A in the osteoblast-like cell line, MG-63., Ann Rheum Dis, 58, 169, 10.1136/ard.58.3.169 · DOI
- Mor, 2005, Identification of aldolase as a target antigen in Alzheimers disease., J Immunol, 175, 3439, 10.4049/jimmunol.175.5.3439 · DOI · Paper page
- Korf, 1992, . Immunocytochemical demonstration of interphotoreceptor retinoid-binding protein in cerebellar medulloblastoma., Acta Neuropathol, 83, 482, 10.1007/BF00310024 · DOI
- Powell, 2010, Treatment of melanoma-associated retinopathy., Curr Treat Options Neurol, 12, 54, 10.1007/s11940-009-0057-x · doi:10.1007/s11940-009-0057-x
- Subhadra, 2008, . Improvement in visual fields in a patient with melanoma-associated retinopathy treated with intravenous immunoglobulin., J Neuroophthalmol, 28, 23, 10.1097/WNO.0b013e31816754c4 · doi:10.1097/wno.0b013e31816754c4
- Dalakas, 1998, Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases., Neurology, 51, S2, 10.1212/WNL.51.6_Suppl_5.S2 · DOI
- Jacobzone, 2004, . Corticosteroid treatment for melanoma-associated retinopathy: effect on visual acuity and electrophysiologic findings., Arch Dermatol, 140, 1258, 10.1001/archderm.140.10.1258 · doi:10.1001/archderm.140.10.1258
- Gass, 1990, . Bilateral diffuse uveal melanocytic proliferation in patients with occult carcinoma., Arch Ophthalmol, 108, 527, 10.1001/archopht.1990.01070060075053 · doi:10.1001/archopht.1990.01070060075053
- ONeal, 2003, . Bilateral diffuse uveal melanocytic proliferation associated with pancreatic carcinoma: a case report and literature review of this paraneoplastic syndrome., Surv Ophthalmol, 48, 613, 10.1016/j.survophthal.2003.08.005 · doi:10.1016/j.survophthal.2003.08.005
- Mandelcorn, 2009, . Ocular paraneoplastic syndrome: a case of bilateral diffuse uveal melanocytic proliferation., Retina, 29, 1375, 10.1097/IAE.0b013e3181b2106b · doi:10.1097/iae.0b013e3181b2106b
- Chahud, 2001, . Bilateral diffuse uveal melanocytic proliferation associated with extraocular cancers: review of a process particularly associated with gynecologic cancers., Am J Surg Pathol, 25, 212, 10.1097/00000478-200102000-00009 · doi:10.1097/00000478-200102000-00009
- Miles, 2012, . A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytes., Retina, 32, 1959, 10.1097/IAE.0b013e3182618bab · doi:10.1097/iae.0b013e3182618bab
- Rohrbach, 1990, . Simultaneous bilateral diffuse melanocytic uveal hyperplasia., Am J Ophthalmol, 110, 49, 10.1016/S0002-9394(14)76937-5 · doi:10.1016/s0002-9394(14)76937-5
- Sen, 2006, . Presymptomatic diagnosis of bronchogenic carcinoma associated with bilateral diffuse uveal melanocytic proliferation., Clin Experiment Ophthalmol, 34, 156, 10.1111/j.1442-9071.2006.01145.x · doi:10.1111/j.1442-9071.2006.01145.x
- Saito, 2005, . Bilateral diffuse uveal melanocytic proliferation in a patient with cancer-associated retinopathy., Am J Ophthalmol, 140, 942, 10.1016/j.ajo.2005.05.048 · doi:10.1016/j.ajo.2005.05.048
- Mets, 2011, . Bilateral diffuse uveal melanocytic proliferation with a positive ophthalmoscopic and visual response to plasmapheresis., Arch Ophthalmol, 129, 1235, 10.1001/archophthalmol.2011.277 · doi:10.1001/archophthalmol.2011.277
- Jaben, 2011, . The potential role of plasma exchange as a treatment for bilateral diffuse uveal melanocytic proliferation: a report of two cases., J Clin Apher, 26, 356, 10.1002/jca.20310 · doi:10.1002/jca.20310
- Ritland, 2000, Bilateral diffuse uveal melanocytic proliferation and uterine cancer. A case report., Acta Ophthalmol Scand, 78, 366, 10.1034/j.1600-0420.2000.078003366.x · doi:10.1034/j.1600-0420.2000.078003366.x
- Heckenlively, 1985, . Autoimmunity in hereditary retinal degenerations. II. Clinical studies: antiretinal antibodies and fluorescein angiogram findings., Br J Ophthalmol, 69, 758, 10.1136/bjo.69.10.758 · DOI
- Adamus, 2009, Molecular biomarkers for autoimmune retinopathies: significance of anti-transducin-alpha autoantibodies., Exp Mol Pathol, 87, 195, 10.1016/j.yexmp.2009.08.003 · DOI
- Dawson, 2001, . Distant cancer effects on standardised testing of peripheral vision., Br J Ophthalmol, 85, 291, 10.1136/bjo.85.3.291 · doi:10.1136/bjo.85.3.291
- Ohta, 2011, Slowly progressive non-neoplastic autoimmune-like retinopathy., Graefes Arch Clin Exp Ophthalmol, 249, 155, 10.1007/s00417-010-1436-4 · doi:10.1007/s00417-010-1436-4
- Peek, 1998, . Muller cell-specific autoantibodies in a patient with progressive loss of vision., Invest Ophthalmol Vis Sci, 39, 1976
- Adamus, 2009, Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy., J Autoimmun, 32, 133, 10.1016/j.jaut.2009.02.001 · DOI
- Heckenlively, 2010, Controversies of diagnosing autoimmune retinopathy., Arch Ophthalmol, 128, 147
- Heckenlively, 2010, Controversies of diagnosing autoimmune retinopathy., Arch Ophthalmol, 128, 147
- Braithwaite, 2012, Autoimmune retinopathy., Ophthalmologica, 228, 131, 10.1159/000338240 · DOI
- Faez, 2013, Concordance of antiretinal antibody testing results between laboratories in autoimmune retinopathy., JAMA Ophthalmol, 131, 113, 10.1001/jamaophthalmol.2013.574 · doi:10.1001/jamaophthalmol.2013.574
- Rahimy, 2013, Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management., Surv Ophthalmol, 58, 430, 10.1016/j.survophthal.2012.09.001 · DOI · Paper page
- Grange, 2014, Autoimmune retinopathy., Am J Ophthalmol, 157, 266, 10.1016/j.ajo.2013.09.019 · DOI
- Wood, 2010, . Alloimmune retinopathy associated with antibodies to transducin-alpha as a complication of chronic graft-versus-host disease., Biol Blood Marrow Transplant, 16, 135, 10.1016/j.bbmt.2009.06.012 · DOI
- Shimazaki, 2008, . Frequency of anti-retinal antibodies in normal human serum., J Neuroophthalmol, 28, 5, 10.1097/WNO.0b013e318167549f · DOI
- Wolfensberger, 2000, . Antiretinal antibodies associated with cystoid macular edema in German., Klin Monbl Augenheilkd, 216, 283, 10.1055/s-2000-10561 · DOI
- Chan, 1985, . Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcets disease, and sympathetic ophthalmia., Ophthalmology, 92, 1025, 10.1016/S0161-6420(85)33911-8 · DOI
- Chan, 1987, . Immunopathology of ocular onchocerciasis. 2. Anti-retinal autoantibodies in serum and ocular fluids., Ophthalmology, 94, 439, 10.1016/S0161-6420(87)33452-9 · doi:10.1016/s0161-6420(87)33452-9
- Whittle, 1998, . Human antiretinal antibodies in toxoplasma retinochoroiditis., Br J Ophthalmol, 82, 1017, 10.1136/bjo.82.9.1017 · doi:10.1136/bjo.82.9.1017
- Yanagi, 2006, . Autoimmune retinopathy after chronic renal allograft rejection., Arch Ophthalmol, 124, 418, 10.1001/archopht.124.3.418 · doi:10.1001/archopht.124.3.418
- Dot, 2005, Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung., Am J Ophthalmol, 139, 746, 10.1016/j.ajo.2004.10.044 · DOI
- Saito, 2013, . Autoimmune retinopathy associated with colonic adenoma., Graefes Arch Clin Exp Ophthalmol, 251, 1447, 10.1007/s00417-012-2131-4 · doi:10.1007/s00417-012-2131-4
- Pfohler, 2007, . Mitofilin and titin as target antigens in melanoma-associated retinopathy., Int J Cancer, 120, 788, 10.1002/ijc.22384 · DOI
- Mahdi, 2010, A case of autoimmune retinopathy associated with thyroid carcinoma., Ocul Immunol Inflamm, 18, 322, 10.3109/09273941003802379 · DOI
- Palmowski, 2002, . Bilateral multifocal chorioretinopathy in a woman with cutaneous malignant melanoma., Arch Ophthalmol Dec, 120, 1756
- Adamus, 2009, Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy., Autoimmun Rev Mar, 8, 410, 10.1016/j.autrev.2009.01.002 · DOI · Paper page
Cited by
Rituximab for Non-Infectious Uveitis and Scleritis
Ng, C. C., Sy, A., & Cunningham, E. T. (2021) · Journal of Ophthalmic Inflammation and Infection · doi:10.1186/s12348-021-00252-4 · Cited by 40
Metadata
- Authors
- Grewal, D. S., Fishman, G. A., & Jampol, L. M.
- Venue
- Retina
- Published
- 2014-05
- Volume
- 34
- Issue
- 5
- Pages
- 827-845
- ISSN
- 0275-004X (ISSN-L)
- OpenAlex
- W1983535430
- Cited by
- 173
- References
- 4
- FWCI
- 7.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AUTOIMMUNE RETINOPATHY AND ANTIRETINAL ANTIBODIES: A REVIEW. https://app.cochat.ai/papers/10.1097/iae.0000000000000119
- The paper
- Grewal, D. S., Fishman, G. A., & Jampol, L. M. (2014). AUTOIMMUNE RETINOPATHY AND ANTIRETINAL ANTIBODIES: A REVIEW. Retina. https://doi.org/10.1097/iae.0000000000000119
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.